CareCloud, Inc. (CCLD)

Over the past six months, CareCloud held its Q2 2025 results conference call and reported strong third-quarter revenue growth, upgrading its full-year 2025 revenue expectations. The company completed strategic acquisitions, including Medsphere and Map App, expanding its presence in the hospital market. CareCloud has made progress in embedding AI across its platform, with a pilot Agentic AI Front Desk handling patient calls. Analysts raised price targets for CCLD following the Q3 results. A director of CareCloud sold shares of stock, and the company announced a plan to pay double monthly dividends on its Series B Preferred Stock. CareCloud presented at conferences, highlighting its AI innovation, strategic acquisitions, and growth strategy.

Information explicitly detailing the demand seasonality for CareCloud, Inc.'s products and services is not readily available. Demand for its services is likely tied to the ongoing operations and needs of medical practices, hospitals, and health systems, which are generally consistent throughout the year. Minor fluctuations might be related to healthcare industry cycles, budget allocations, or changes in regulatory requirements. The company's focus on digital health offerings suggests a continuous demand driven by the ongoing need for patient care and management.

CareCloud, Inc. is a healthcare IT company providing cloud-based solutions and business services to healthcare providers and hospitals across the United States. The company's offerings include cloud-based software for clinical, financial, and patient workflows, technology-enabled services like RCM and RPA, digital health offerings for CCM and RPM, and AI solutions for improved clinical documentation and patient engagement. CareCloud serves approximately 40,000 providers across 80 medical specialties.

CareCloud primarily serves medical practices, hospitals, and health systems nationwide in the United States. To gain a competitive edge in costs and access a professional workforce, CareCloud utilizes four offshore delivery centers located in Pakistan and Sri Lanka.

CareCloud's brand reputation in the past year appears to be generally positive, with a focus on innovation and growth in healthcare technology. The company has been promoting its AI innovation and strategic acquisitions, highlighting its commitment to improving patient care. The Q3 2025 earnings report showed strong revenue growth, positively impacting market perception. However, shareholders have been substantially diluted, and there has been significant insider selling, which could be a point of concern. Financial analysis indicates challenges with revenue growth despite recent growth.

CareCloud has a mixed ownership structure consisting of institutional, retail, and individual investors. Institutional investors own approximately 10.16% to 20.8% of the stock, with major holders including Vanguard and BlackRock. Retail investors hold a significant portion, approximately 64.3% to 81.67% of the stock. Insiders own approximately 2.07% to 14.9% of the company's stock, with Mahmud Haq being a top individual shareholder. There has been significant insider selling over the past three months.